This invention relates to (+)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene and to pharmaceutically acceptable acid addition salts thereof and the method for the treatment of human beings suffering from nervous disarrangements, in particular migraine, using these compounds.
本发明涉及(+)-2-[1-(2,6-二
氯苯氧基)乙基]-1,3-二氮杂环戊-2-烯及其药学上可接受的酸盐,以及使用这些化合物治疗患有神经紊乱的人类,特别是偏头痛的方法。